Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07049289

Telemonitoring in Arterial Hypertension

Prospective, randomized trial to assess the effects of a telemedical approach of antihypertensive treatment in comparison with standard care.

Total patient number: 60 patients.

* Intervention group: biweekly telephone calls * Control group: standard of care

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Arterial Hypertension Cardiovascular Diseases Hypertension Uncontrolled Hypertension Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Heart Centre Leipzig

Leipzig, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Confirmed arterial hypertension with systolic or diastolic blood pressure >140/90 mmHg in standardized office blood pressure measurement
  • Treatment with 1 to ≤4 antihypertensive drug classes
  • Age >18 years
  • Written informed consent

Exclusion criteria

  • Pregnancy
  • Participation in other randomized trials
  • Patients under legal supervision or guardianship

Treatment and study plan

Telemonitoring

Other

Patients randomized to intervention group will receive biweeky telephone calls and adaption of antiyhpertensive medication if needed

Other names: telemedicine

Primary outcomes

  1. Time in blood pressure target range from randomization through 6 months

    Time frame: 6 months

    Time in target range of each blood pressure measurement in first 6 months between control and intervention group

Secondary outcomes

  1. Time in target range months 6 to 12

    Time frame: 6 months (7-12 months)

    Time in target range of each blood pressure measurement between control and intervention group from months 7 to 12

  2. Medication adherence as assessed by blood/urine sampling after 6 and 12 months

    Time frame: 0, 6 and 12 months

    Medication adherence as assessed by blood/urine sampling after 6 and 12 months

Sponsors and collaborators

Lead sponsor

Heart Center Leipzig - University Hospital

Other

Registry information

Official study title

Randomized Trial for Telemedical Support Versus Standard Treatment to Control Arterial Hypertension

Acronym: REMOTE-Control

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Jul 3, 2025
Registry last updated
Jul 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.